Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly

被引:71
作者
Morikawa, Y
Hockley, DJ
Nermut, MV
Jones, IM
机构
[1] Kitasato Inst, Minato Ku, Tokyo 1088642, Japan
[2] Natl Inst Biol Stand & Controls, S Mimms EN6 3QG, Herts, England
[3] NERC, Inst Virol & Environm Microbiol, Oxford OX1 3SR, England
关键词
D O I
10.1128/JVI.74.1.16-23.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 1 Gag protein is cotranslationally myristoylated at the N terminus and targeted to the plasma membrane, where virus particle assembly occurs. Particle assembly requires the ordered multimerization of Gag proteins, yet there is little direct evidence of intermediates of the reaction or of the domains that lead to each stage of the oligomerization process. In this study, following the expression in insect cells of C-terminally truncated Gag proteins and their purification, both the multimeric nature of each Gag protein and the ability to form Gag virus-like particles (VLP) were analyzed. Our results show that (i) the matrix (MA) domain forms a trimer and contributes to a similar level of oligomerization of the assembly competent Gag; (ii) the p2 domain, located at the capsid/nucleocapsid junction, is essential for a higher order of multimerization (>1,000 kDa); (iii) the latter multimerization is accompanied by a change in Gag assembly morphology from tubes to spheres and results in VLP production; and (iv) N-terminal myristoylation is not required for either of the multimerization stages but plays a key role in conversion of these multimers to Gag VLP. We suggest that the Gag trimer and the >1,000-kDa multimer are intermediates in the assembly reaction and form before Gag targeting to the plasma membrane. Our data identify a minimum of three stages for VIE development and suggest that each stage involves a separate domain, MA, p2, or N-terminal myristoylation. each of which contributes to HIV particle assembly.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 57 条
[1]   A putative α-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly [J].
Accola, MA ;
Höglund, S ;
Göttlinger, HG .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2072-2078
[2]   SPECIFIC BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG POLYPROTEIN AND NUCLEOCAPSID PROTEIN TO VIRAL RNAS DETECTED BY RNA MOBILITY SHIFT ASSAYS [J].
BERKOWITZ, RD ;
LUBAN, J ;
GOFF, SP .
JOURNAL OF VIROLOGY, 1993, 67 (12) :7190-7200
[3]   The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly [J].
Borsetti, A ;
Ohagen, Å ;
Göttlinger, HG .
JOURNAL OF VIROLOGY, 1998, 72 (11) :9313-9317
[4]   MYRISTOYLATION-DEPENDENT REPLICATION AND ASSEMBLY OF HUMAN IMMUNODEFICIENCY VIRUS-1 [J].
BRYANT, M ;
RATNER, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) :523-527
[5]   SELF-ASSEMBLY IN-VITRO OF PURIFIED CA-NC PROTEINS FROM ROUS-SARCOMA VIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
CAMPBELL, S ;
VOGT, VM .
JOURNAL OF VIROLOGY, 1995, 69 (10) :6487-6497
[6]  
CARRIERE C, 1995, J VIROL, V69, P2366
[7]  
Craven RC, 1996, CURR TOP MICROBIOL, V214, P65
[8]   SPECIFIC BINDING OF HIV-1 NUCLEOCAPSID PROTEIN TO PSI-RNA IN-VITRO REQUIRES N-TERMINAL ZINC-FINGER AND FLANKING BASIC-AMINO-ACID RESIDUES [J].
DANNULL, J ;
SUROVOY, A ;
JUNG, G ;
MOELLING, K .
EMBO JOURNAL, 1994, 13 (07) :1525-1533
[9]   The role of nucleocapsid of HIV-1 in virus assembly [J].
Dawson, L ;
Yu, XF .
VIROLOGY, 1998, 251 (01) :141-157
[10]   FUNCTIONAL DOMAINS OF THE CAPSID PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
DORFMAN, T ;
BUKOVSKY, A ;
OHAGEN, A ;
HOGLUND, S ;
GOTTLINGER, HG .
JOURNAL OF VIROLOGY, 1994, 68 (12) :8180-8187